Oncolytics Biotech Inc. (ONCY) short interest & options flow
NASDAQOncolytics Biotech heads into its May 8 earnings report with the most compelling signal coming not from the options desk, but from the boardroom. Ten insiders bought shares on or around February 12 — including the CEO, CFO, Chief Medical Officer, Chairman, and multiple independent directors. Every recent insider transaction has been a purchase. Net insider buying over the past 90…
ONCY SI utilization at 92.52%, near the 52-week high of 100%, indicating tight borrow conditions for short sellers.
- Market cap
- $49M
- Next earnings
- 12 Nov 2026
Key data as of 12 Nov 2026
Latest signals on ONCY
- Utilization
ONCY SI utilization at 92.52%, near the 52-week high of 100%, indicating tight borrow conditions for short sellers.
- Signal
ONCY utilization hits 94.17%, near its 52-week peak of 100%, signaling tight borrow availability for short sellers.
ONCY news and analysis
RSSNo long-form analysis yet for ONCY. Pulse alerts and the live data picture are available on ORTEX.
Open ONCY on ORTEX →Want the live picture for ONCY?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ONCY — free to start on ORTEX.
Sign up for free →Open ONCY on ORTEX